Prevention of early asthma in childhood trial with pranlukast in Mie; PROACT-Mie
Phase 4
- Conditions
- Wheezing syndrome in infants
- Registration Number
- JPRN-UMIN000001918
- Lead Sponsor
- Study group of pediatric asthma in Mie prefecture
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Wheezing due to congenital anatomical anomaly, wheezing due to mediatinal neoplasm, croup syndrome, foreign body in the airways, heart diseases, pneumonia, tuberculosis, administration of leukotriene receptor antagonists, cromolyns, anti-histamines, severe liver/renal/heart diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method wheezing episodes during and after treatment with pranlukast
- Secondary Outcome Measures
Name Time Method rate of dropout because of persistent asthma symptoms